Dan C. v. Directors Guild of America

Plaintiff: Dan C. 

Defendant: Directors Guild of America 

Court: United States Court of Appeals, Ninth Circuit. 

Case Number: Case No. 24-3203 

Judgment Date: June 2, 2025 

Case Overview: 

Dan C., on behalf of his minor son (R.C.), sought coverage from the Directors Guild of America – Producer Health Plan for residential mental health treatment necessitated by severe behavioral and psychiatric conditions. The plan denied coverage, asserting that the treatment was not medically necessary under its criteria. Dan C. challenged the denial under ERISA, arguing that the plan improperly evaluated medical necessity and failed to provide a fair review of his claim. The district court ruled in his favor, and the plan was appealed to the Ninth Circuit. 

Court Findings: 

De Novo Review Properly Applied: 

The court held that de novo review applied because the plan failed to clearly delegate discretionary authority to the entity making the benefit determination. This allowed the court to independently evaluate whether benefits were owed. 

Medical Necessity Established: 

The court upheld the finding that residential treatment was medically necessary, citing substantial evidence that R.C. posed a danger to himself and others and suffered from severe functional impairments that could not be managed at a lower level of care. 

Procedural Violations of ERISA: 

The plan failed to provide adequate notice of the true basis for its denial, particularly its expectation that lower levels of care (such as intensive outpatient or partial hospitalization) be attempted first. This deprived Dan C. of a meaningful opportunity to respond and violated ERISA’s requirement of a “full and fair review.” 

Inadequate and Misleading Denial Process: 

The court found that the plan’s communications were unclear and inconsistent, preventing meaningful dialogue and obscuring the evidence needed to support the claim. 

Logical Flaw: 

The court identified a fundamental flaw in the plan’s reasoning: it denied coverage based on criteria it never clearly disclosed to the claimant. While internally relying on requirements for lower levels of care, the plan communicated a different rationale externally, preventing Dan C. from addressing the actual basis for the denial. This lack of transparency undermined the integrity of the review process and violated ERISA’s procedural safeguards. 

Outcome: 

The Ninth Circuit affirmed the judgment in Dan C.’s favor on his ERISA claim for benefits, confirming his entitlement to coverage for his son’s residential treatment. Although the court reversed a separate fiduciary-duty ruling as duplicative, it made clear that this did not affect Dan C.’s recovery of benefits. The case was remanded solely to clarify that relief was awarded under ERISA’s benefits provision. 

Implications: 

This decision highlights several critical principles in ERISA litigation: 

• Courts will apply de novo review where insurers fail to clearly delegate discretionary authority. 
• Insurers must clearly communicate all bases for denial, including any requirements regarding lower levels of care. 
• A failure to engage in a meaningful dialogue with claimants violates ERISA’s procedural protections. 
• Strong clinical evidence of risk and functional impairment will support medical necessity for residential treatment. 

The case reinforces that insurers cannot rely on undisclosed criteria or shifting rationales to deny claims, particularly in complex mental health cases involving vulnerable patients.